| GTO ID | GTC1953 |
| Trial ID | NCT03635632 |
| Disease | Osteosarcoma | Neuroblastoma | Breast Phyllodes Tumor | Uveal Melanoma | Ewing Sarcoma | Rhabdomyosarcoma |
| Altered gene | C7R|GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | C7R/GD2 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | C7R-GD2.Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) |
| Year | 2019 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-42207 GAIL-N |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||